RE: market cap10 May 2020 21:18
Ocelot,
You are still only quoting the Operating loss which adds a net £606,000 financing costs to the £4.788 loss you previously quoted.
But you are ignoring the cost of running the subsidiaries, which in the 2018/19 year had an offset of the oil revenue..
Here's a simple sum. At the beginning of the period (end September 2018) they had £12.427mm cash and cash equivalents.
At the end of the latest accounts period (end September 2019) they had £6.892mm - so £5.535mm less.
But they raised £9mm cash from a placing (£3.5mm) and YA/Riverfort (£5.5mm) so they spent £14.535mm.
They also received £2.411mm for oil sales, so total expenditure was £16.946mm.
However £5mm of that expenditure was for the purchase of Tellurian's 35% of HH licences, an extraordinary item and some of the money raised was specifically for that.
So total expenditure excluding the Tellurian transaction was £11.946mm. This in a year when drilling HH-2z had only just begun so the main expenditures were the testing, preparing for drilling, salaries, external consultancy and consultancy costs of preparing and submitting planning applications.
So if they failed to make cost savings and continued to spend at that level and did not raise any more cash by any method then to break even the group would need HH oil revenue of nearly £12mm (though there wouldn't be the expenses of cash raising) - not £4.788mm, or £5.394mm.
They have already raised £3.125mm 7 months into this financial year but have had expenditure of drilling HH-2 & HH-2z plus the continued testing of HH-1, the remedial costs for HH-2z, and it's subsequent clean-up and testing.
UKOG has said they are making cost savings so the 2018/19 expenditure figures are hopefully wildly more than they are currently.
But you are being selective by only including the losses of the operating activities when there are substantial investing activities, and these expenditures were probably mostly incurred in the testing at HH.